港交所(0388.HK)半日跌1.31%百威亚太取消在港IPO、阿里下调募资额
格隆汇7月15日丨港交所(0388.HK)今日出现明显下跌,盘中一度跌2.18%至269.4港元,创出1个月新低,半日跌1.31%,报271.8港元,成交9.94亿港元,最新总市值3420亿港元。

百威英博已宣布取消原本有望成为今年全球最大规模IPO的子公司百威亚太的在港上市计划,使得港交所原指望的年内IPO总量瞬间缩水一半。
此外,上周还有报道称,出于对港股市场不景气的考虑,阿里巴巴集团确认下调港股上市募资额度至100亿美元(此前据称募资200亿美元)。此前有报道称,阿里巴巴于6月中旬向港交所提交了上市申请,计划9月底挂牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.